Literature DB >> 16390324

New roles for matrix metalloproteinases in metastasis.

Mélanie Demers1, Julie Couillard, Simon Bélanger, Yves St-Pierre.   

Abstract

To form tumors successfully at sites remote from the primary tumor, metastatic cells must be endowed with particular properties. They must detach from the primary tumor and enter the blood circulation, where they must resist hemodynamic shearstress, "home" to the target organ, successfully extravasate, and then migrate through dense stroma to a site favorable for tumor growth. Recent results with genetically engineered mouse models have generated data which clearly challenge the classic dogma stating that matrix metalloproteinases (MMPs) promote metastasis solely by modulating the remodeling of extracellular matrix (ECM). Instead, it is becoming clear that MMPs and their natural inhibitors have multiple biological functions that not only challenge our view on how MMPs promote metastasis, but also raise for the first time the idea that secretion of MMPs by the host could protect it from tumor growth, at least in some types of cancer or at specific stages of tumor progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16390324     DOI: 10.1615/critrevimmunol.v25.i6.30

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  12 in total

1.  Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapy.

Authors:  C J Kleber; A Spiess; J B Kleber; U Hinz; S Holland-Cunz; J Weiss
Journal:  Eur J Pediatr       Date:  2011-12-28       Impact factor: 3.183

2.  Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas.

Authors:  Oscar Fernández-Guinea; Almudena Álvarez-Cofiño; Noemí Eiró; Luis O González; José M del Casar; Belen Fernandez-Garcia; Maria L Lamelas; Alejandro Andicoechea; Francisco J Vizoso
Journal:  Int J Clin Oncol       Date:  2012-06-12       Impact factor: 3.402

3.  Enzyme-Induced Matrix Softening Regulates Hepatocarcinoma Cancer Cell Phenotypes.

Authors:  Youyun Liang; Nicholas Edwin Clay; Kathryn M Sullivan; Jiayu Leong; Altug Ozcelikkale; Max H Rich; Min Kyung Lee; Mei-Hsiu Lai; Hojeong Jeon; Bumsoo Han; Yen Wah Tong; Hyunjoon Kong
Journal:  Macromol Biosci       Date:  2017-07-06       Impact factor: 4.979

4.  Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer.

Authors:  Lucía González; Noemí Eiró; Luis O González; Alejandro Andicoechea; Esther Barbón; José L García-Muñiz; Francisco J Vizoso
Journal:  Dig Dis Sci       Date:  2012-04-10       Impact factor: 3.199

5.  Protein phosphatase 2A regulation of markers of extracellular matrix remodelling in hepatocellular carcinoma cells: functional consequences for tumour invasion.

Authors:  M P Ward; J P Spiers
Journal:  Br J Pharmacol       Date:  2017-04-07       Impact factor: 8.739

6.  Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer.

Authors:  María Fernanda García; Salomé González-Reyes; Luis Ovidio González; Sara Junquera; Nana Berdize; José Manuel Del Casar; María Medina; Francisco José Vizoso
Journal:  Int J Exp Pathol       Date:  2010-04-20       Impact factor: 1.925

7.  Mechanistic studies of the triggered release of liposomal contents by matrix metalloproteinase-9.

Authors:  Adekunle I Elegbede; Jayati Banerjee; Andrea J Hanson; Shakila Tobwala; Bratati Ganguli; Rongying Wang; Xiaoning Lu; D K Srivastava; Sanku Mallik
Journal:  J Am Chem Soc       Date:  2008-07-22       Impact factor: 15.419

8.  Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.

Authors:  Saran Feng; Jiannong Cen; Yihong Huang; Hongjie Shen; Li Yao; Yuanyuan Wang; Zixing Chen
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

9.  Study of matrix metalloproteinases and their inhibitors in prostate cancer.

Authors:  S Escaff; J M Fernández; L O González; A Suárez; S González-Reyes; J M González; F J Vizoso
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

10.  Study of matrix metalloproteinases and their inhibitors in breast cancer.

Authors:  F J Vizoso; L O González; M D Corte; J C Rodríguez; J Vázquez; M L Lamelas; S Junquera; A M Merino; J L García-Muñiz
Journal:  Br J Cancer       Date:  2007-03-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.